Octreotide acetate and Loperamide hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Octreotide acetate and Loperamide hydrochloride. Common interactions include weight decreased among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people who take Octreotide acetate and Loperamide hydrochloride have. It is created by eHealthMe based on reports of 10 people who take Octreotide acetate and Loperamide hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 07, 2022

10 people who take Octreotide acetate and Loperamide hydrochloride together, and have interactions are studied.


What is Octreotide acetate?

Octreotide acetate has active ingredients of octreotide acetate. eHealthMe is studying from 1,903 Octreotide acetate users for its effectiveness, alternative drugs and more.

What is Loperamide hydrochloride?

Loperamide hydrochloride has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 7,602 Loperamide hydrochloride users for its effectiveness, alternative drugs and more.

Number of Octreotide acetate and Loperamide hydrochloride reports submitted per year:

Octreotide acetate and Loperamide hydrochloride drug interactions.

Common Octreotide Acetate and Loperamide Hydrochloride drug interactions by gender *:

female:

  1. Weight decreased
  2. Cholelithiasis
  3. Disease progression
  4. Fatigue
  5. Musculoskeletal chest pain
  6. Myocardial infarction
  7. Urosepsis
  8. Abdominal distension
  9. Abdominal pain
  10. Arthralgia

male:

  1. Abdominal pain
  2. Anaemia
  3. Gastrointestinal haemorrhage
  4. Graft versus host disease
  5. Interstitial lung disease
  6. Malaise
  7. Melaena
  8. Metabolic acidosis
  9. Renal failure
  10. Respiratory failure

Common Octreotide Acetate and Loperamide Hydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood pressure systolic increased
  2. Electrocardiogram st-t change
  3. Hypotension
  4. Mitral valve incompetence
  5. Myocardial ischaemia
  6. Ventricular bigeminy
  7. Ventricular hypokinesia
  8. Ventricular tachycardia

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Blood lactate dehydrogenase increased
  3. C-reactive protein increased
  4. Dehydration
  5. Drug ineffective
  6. Faeces discoloured
  7. Graft versus host disease
  8. Interstitial lung disease
  9. Malaise
  10. Melaena

60+:

  1. Fatigue
  2. Cholelithiasis
  3. Malignant neoplasm progression
  4. Metastases to liver
  5. Metastases to lymph nodes
  6. Nausea
  7. Oedema peripheral
  8. Stomatitis
  9. Vomiting
  10. Weight decreased

Common conditions people have *:

  1. Nausea (feeling of having an urge to vomit): 2 people, 20.00%
  2. Infection: 2 people, 20.00%
  3. Vitamin B12 Deficiency: 1 person, 10.00%
  4. Insomnia (sleeplessness): 1 person, 10.00%
  5. Cachexia (loss of weight): 1 person, 10.00%
  6. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 10.00%
  7. Depression: 1 person, 10.00%
  8. Dizziness: 1 person, 10.00%
  9. Hiv Infection: 1 person, 10.00%
  10. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Octreotide acetate and Loperamide hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Octreotide acetate and Loperamide hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Octreotide acetate side effects:

Browse all side effects of Octreotide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Loperamide hydrochloride side effects:

Browse all side effects of Loperamide hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Octreotide acetate interactions:

Browse all interactions between Octreotide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Loperamide hydrochloride interactions:

Browse all interactions between Loperamide hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on octreotide acetate and loperamide hydrochloride (the active ingredients of Octreotide acetate and Loperamide hydrochloride, respectively), and Octreotide acetate and Loperamide hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Octreotide acetate and Loperamide hydrochloride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: